Introduction

The book examines the evolutionary trajectory of medical biotechnology (MBT) in India under a neoliberal political economy regime. It examines the role of three important actors—namely, the state, academia, and finance capital—and argues that these actors enable what is called a double-layered accumulation in a single production process through MBT start-ups.